Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.62 |
| ▸ | SELP | P16109 | 1/20 | 0.62 |
| ▸ | SELE | P16581 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | MPI | P34949 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | ERN1 | O75460 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 3/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL562147 | 0.90 | ERN1 (0.63) | SELLSELPSELEMAPTKDM4E | |
| SCHEMBL14430069 | 0.84 | ERN1 (0.53) | SELLSELPSELEMAPTKDM4E | |
| SCHEMBL7520392 | 0.83 | ERN1 (0.57) | SELLSELPSELEMAPTKDM4E | |
| SCHEMBL10053940 | 0.83 | ACHE (0.59) | SELLSELPSELEMAPTKDM4E | |
| SCHEMBL5727264 | 0.83 | ACHE (0.52) | SELLSELPSELEMAPTKDM4E | |
| SCHEMBL678214 | 0.83 | ERN1 (0.57) | SELLSELPSELEMAPTKDM4E | |
| SCHEMBL31496789 | 0.83 | ACHE (0.52) | SELLSELPSELEMAPTKDM4E | |
| SCHEMBL26627967 | 0.82 | ALDH1A1 (0.78) | SELLSELPSELEMAPTKDM4E | |
| Methoxymethane SCHEMBL11591595 | 0.81 | SELL (0.82) | SELLSELPSELEMAPTKDM4E | |
| SCHEMBL29421895 | 0.81 | ACHE (0.70) | SELLSELPSELEMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059153-A1 | BICYCLIC QUINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | IC-MedTech Corp. | 2025-02-20 | — | — | US | disclosed |
| EP-3571180-B1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | UNIV LEUVEN KATH (BE) | 2024-12-18 | — | — | EP | disclosed |
| EP-4465981-A1 | BICYCLIC QUINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | IC-Medtech Corp. (US) | 2024-11-27 | — | — | EP | disclosed |
| CN-118891036-A | Bicyclic quinones, pharmaceutical compositions and therapeutic uses | IC医药科技公司 | 2024-11-01 | — | — | CN | disclosed |
| WO-2023141410-A1 | BICYCLIC QUINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | IC-MedTech Corp. (US) | 2023-07-27 | — | — | WO | disclosed |
| WO-2023141410-A1 | BICYCLIC QUINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | IC-MedTech Corp. (US) | 2023-07-27 | — | — | WO | disclosed |
| US-20210070684-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2021-03-11 | — | — | US | disclosed |
| US-10787475-B2 | Methods of making low color lignin | INGEVITY SOUTH CAROLINA, LLC (US) | 2020-09-29 | — | — | US | disclosed |
| CN-111411089-A | Method for efficiently synthesizing rare glycyrrhiza triterpenes by saccharomyces cerevisiae through controllable oxidation | 北京理工大学 | 2020-07-14 | — | — | CN | disclosed |
| EP-3571180-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | Katholieke Universiteit Leuven (BE) | 2019-11-27 | — | — | EP | disclosed |
| WO-2007147480-A2 | POLYMORPHIC FORMS AND PROCESS | MERCK PATENT GMBH (DE) | 2007-12-27 | — | — | WO | disclosed |
| US-20070276011-A1 | Plasminogen Activator Inhibitor-1 Inhibitor | INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) | 2007-11-29 | — | — | US | disclosed |
| US-20070276011-A1 | Plasminogen Activator Inhibitor-1 Inhibitor | INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) | 2007-11-29 | — | — | US | disclosed |
| WO-2007054138-A1 | SUBSTITUTED TETRAHYDROQUINOLINES | MERCK PATENT GMBH (DE) | 2007-05-18 | — | — | WO | disclosed |
| US-4113484-A | ELECTROPHOTOGRAPHIC ELEMENTS AND PROCESSES | EASTMAN KODAK COMPANY (US) | 1978-09-12 | — | — | US | disclosed |
| US-4095981-A | Photographic material containing an energy-sensitive organic o-nitroarylidene dye and physical development process of forming an image with said material | EASTMAN KODAK COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
| US-4046569-A | PHYSICAL DEVELOPMENT OF PD(II) PHOTOSENSITIVE COMPLEXES WITH A LEUCOPHTHALOCYANINE DYE AND A REDUCING AGENT THEREFOR | EASTMAN KODAK COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-4042392-A | GROUP 8B OR 1B METALS, FORMAZAN DYES | EASTMAN KODAK COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
| US-3989732-A | Photosensitive copper (I) complexes | EASTMAN KODAK COMPANY (US) | 1976-11-02 | — | — | US | disclosed |
| US-3980654-A | Copper (II) complexes | EASTMAN KODAK COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059153-A1 | BICYCLIC QUINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | SDHA, NQO1, NDUFA7 | SELL 3942/4885SELP 2382/4885SELE 2895/4885 |
| US-10787475-B2 | Methods of making low color lignin | LPO, LOX, CBR3 | SELL 1321/4885SELP 405/4885SELE 998/4885 |
| US-20210070684-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | MMS19, PCBP1, PBRM1 | SELL 4846/4885SELP 1739/4885SELE 3463/4885 |
| US-20070276011-A1 | Plasminogen Activator Inhibitor-1 Inhibitor | SERPINE1, SERPINC1, SERPINB1 | SELL 385/4885SELP 73/4885SELE 379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.